Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156432 | SCV000206150 | uncertain significance | not specified | 2014-03-14 | criteria provided, single submitter | clinical testing | The 3343-3C>A variant in MYH6 has not been previously reported in individuals wi th cardiomyopathy or in large population studies. This variant is located in the 3' splice region. Computational tools suggest a possible impact to splicing. Ho wever, this information is not predictive enough to determine pathogenicity. Add itional information is needed to fully assess the clinical significance of the v ariant. |
Gene |
RCV001529066 | SCV001768411 | uncertain significance | not provided | 2021-09-20 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports a deleterious effect on splicing; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 179637; Landrum et al., 2016) |
Ambry Genetics | RCV002321651 | SCV002609103 | likely benign | Cardiovascular phenotype | 2023-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV002515019 | SCV003295219 | uncertain significance | Hypertrophic cardiomyopathy 14 | 2022-04-06 | criteria provided, single submitter | clinical testing | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 179637). This variant has not been reported in the literature in individuals affected with MYH6-related conditions. This variant is present in population databases (rs565446762, gnomAD 0.006%). This sequence change falls in intron 25 of the MYH6 gene. It does not directly change the encoded amino acid sequence of the MYH6 protein. It affects a nucleotide within the consensus splice site. |
Diagnostic Laboratory, |
RCV001529066 | SCV001741891 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529066 | SCV001954281 | likely benign | not provided | no assertion criteria provided | clinical testing |